Latest News and Press Releases
Want to stay updated on the latest news?
-
CHARLOTTE, N.C., Aug. 14, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced today that Droxidopa has been granted two orphan medicinal product designations by...
-
CHARLOTTE, N.C., Aug. 7, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) reported financial results for the quarter and six months ended June 30, 2007, presented a...
-
CHARLOTTE, N.C., July 31, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it will report its unaudited financial results for the second quarter ended...
-
CHARLOTTE, N.C., June 27, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) has begun dosing volunteers in its bioequivalence study of CH-1504, an orally available...
-
CHARLOTTE, N.C., May 9, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the first quarter 2007 and presented a quarterly update on...
-
CHARLOTTE, N.C., May 2, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it will report its unaudited financial results for the first quarter ended March...
-
CHARLOTTE, N.C., April 11, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it will be sponsoring a symposium on orthostatic hypotension and hosting its...
-
CHARLOTTE, N.C., March 22, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced the closing of its previously announced $12.5 million private placement with...
-
CHARLOTTE, N.C., March 19, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it has entered into definitive securities purchase agreements with several of...
-
CHARLOTTE, N.C., March 12, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today presented a quarterly update on the Company's development progress, reported financial...